German medical lab equipment maker Sartorius saw a jump in first-quarter net profit to €48.5 million ($55.2 million), up from ...

EQS-News: SARTORIUS AG / Key word (s): Quarter Results/Forecast Strong start to the year: Sartorius achieves significant profitable growth in the first quarter (news with additional features) 16.04 ...

Sartorius reported a strong jump in profitability, with underlying EBITDA rising 12.2% to 263 million euros in the first ...

Sartorius faces uncertainty with leadership changes and high debt levels. Read why DCF valuation models suggest SARTF stock may be overvalued.

Find insight on Sartorius, Praram 9 Hospital and more in the latest Market Talks covering the Health Care sector.

In Europe, the Stoxx Europe 600 declined 0.9% in morning trading. Verallia rose 5.1% and Sartorius Stedim Biotech added 3.4%. On the other hand, Inficon Holding lost 90.2%, and Bunzl slipped 25.2%.

EQS-News: SARTORIUS AG / Key word (s): Mergers & Acquisitions Sartorius to acquire microtissue business MatTek from Swedish BICO AB (news with additional features) 04.04.2025 / 18:00 CET/CEST The ...

The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and ...

After two successive days of solid gains, German stocks are down in negative territory on Wednesday with tariff worries returning to hurt sentiment. New U.S. export restrictions ...

The life science group Sartorius has earned its first certificates from the International Sustainability and Carbon ...

European equities rise as Trump temporarily exempts tech products from tariffs on Chinese imports. The euro also hits 1.14 as ...